D

Decibel Therapeutics

79 employees

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Therapeutics

Date founded

2015

Funding rounds raised

Total raised

$82M

from 20 investors over 20 rounds

D

Decibel Therapeutics raised $82M on November 9, 2020

Investors: S-Cubed Capital, Third Rock Ventures, Surveyor Capital, GV, OrbiMed Advisors, Foresite Capital, S.R. One Ltd, Samsara BioCapital and The Sobrato Organization

D

Decibel Therapeutics raised $55M on June 19, 2018

Investors: S-Cubed Capital, S.R. One Ltd, GV, Bessemer Venture Partners, Regeneron, Foresite Capital, The Longevity Fund and Third Rock Ventures

D

Decibel Therapeutics raised undisclosed on July 6, 2017

Investors: GV

D

Decibel Therapeutics raised $52M on October 15, 2015

Investors: Third Rock Ventures and S.R. One Ltd

FAQ